HONG KONG, Nov. 16, 2015 /PRNewswire/ -- China Cord Blood
Corporation (NYSE: CO) (the "Company") today announced that it
plans to release financial results for the second quarter and first
half of fiscal year 2016 on Monday, November
23, 2015, after market close.
The Company will host a conference call at 8:00 a.m. ET on Tuesday,
November 24, 2015 to discuss its financial performance and
give a brief overview of the Company's recent developments,
followed by a question and answer session. Interested parties can
access the audio webcast through the Company's IR website at
http://ir.chinacordbloodcorp.com. A replay of the webcast will be
accessible two hours after the conference call and available for
three weeks at the same URL as above. Listeners can also access the
call by dialing 1-631-514-2526 or 1-855-298-3404, for US callers,
or +852-5808-3202, for Hong Kong
callers, access code: 2981323.
Please dial in ten minutes prior to the conference call to
ensure proper connection, and be prepared to provide your name and
company name to the operator.
Supplemental financial information referenced in the conference
call and the second quarter and first half of fiscal 2016 earnings
press release will be available at
http://www.chinacordbloodcorp.com, in the section titled "Investor
Center/Press Release", after 4:16 p.m.
ET on Monday, November 23,
2015, and in the Company's Report on Form 6-K for the month
of November 2015, available on the
Securities and Exchange Commission's website at www.sec.gov.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest umbilical
cord blood banking operator in China in terms of geographical coverage and
the only cord blood banking operator with multiple licenses.
Under current PRC government regulations, only one licensed cord
blood banking operator is permitted to operate in each licensed
region and only seven licenses have been authorized as of today.
China Cord Blood Corporation provides cord blood collection,
laboratory testing, hematopoietic stem cell processing and stem
cell storage services. For more information, please visit the
Company's website at
http://www.chinacordbloodcorp.com.
For more information, please contact:
China Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@chinacordbloodcorp.com
ICR, Inc.
William Zima
Tel: (+86) 10-6583-7511
U.S. Tel: (646) 405-5185
Email: william.zima@icrinc.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/china-cord-blood-corporation-to-report-second-quarter-and-first-half-of-fiscal-2016-financial-results-300178996.html
SOURCE China Cord Blood Corporation